---
title: "ATXN10"
date: 2023-05-10 00:00:00
layout: post
categories: Gene
summary: "## Gene: ATXN10"
tags: ['ATXN10', 'GeneticInformation', 'RNAmetabolism', 'SCA10', 'NeurodegenerativeDisease', 'MissenseMutation', 'Prognosis', 'TreatmentOptions']
---

## Gene: ATXN10

### Information

**Genetic Position**: Chromosome 22q13.31 \
**Function for Gene**: ATXN10 (ataxin-10) is involved in RNA metabolism and microRNA biogenesis. \
**Aliases**: ATXN10 (HUGO), Ataxin 10, Atxn10

### External IDs

- HGNC: 861 
- NCBI Entrez: 25814 
- Ensembl: ENSG00000128113 
- OMIM: 611150 
- UniProtKB/Swiss-Prot: Q9UBC5

### Information on ATXN10 Mutations:

**AA Mutation List**:

- p.Gln477Lys (rs387906915)
- p.Ile174Asn (rs1003052896)
- p.Tyr214Cys (rs760345747)


**Mutation Type**:

- Missense mutation 

**Somatic SNVs/InDels**:

- dbSNP IDs: rs387906915, rs1003052896, rs760345747


### Related Diseases

- Spinocerebellar Ataxia 10 (SCA10)
- Machado-Joseph Disease (MJD)/Spinocerebellar Ataxia type 3 (SCA3)
- Parkinson Disease (PD) 

### Treatment and Prognosis

- There is currently no cure for SCA10. Management of symptoms and supportive care is the primary goal of treatment. 
- The prognosis for individuals with SCA10 is variable. Some individuals may experience rapid progression of the disease while others may only exhibit mild symptoms. 

### Drug Response 

- There is currently no identified drug specifically for the treatment of SCA10. 

### References

- Matsuura T, Yamagata T, Burgess DL,  Rasmussen A, Grewal RP, Watase K, Khajavi M, McCall AE, Davis CF, Zu L, Achari M, Pulst SM, Alonso E, Noebels JL, Nelson DL, Zoghbi HY, Ashizawa T (2000) Large expansion of the ATTCT pentanucleotide repeat in spinocerebellar ataxia type 10. Nature Genetics 26:191-194. [DOI: 10.1038/79936]
- Jin Y, Wang C, Liu X, Mu J, Wang Y, Xu H, Bi X (2017) Spinocerebellar ataxia type 10: A review. Neurology India 65:301-308. [DOI: 10.4103/neuroindia.NI_301_16]

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**